This Article Full Text (OnlineFirst PDF) All Versions of this Article: 1087057108315036v1 13/3/218    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Joesch, C. Articles by Albrecht, H. Search for Related Content PubMed PubMed Citation Articles by Joesch, C. Articles by Albrecht, H. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB DIAZEPAM Social Bookmarking                         What's this?

Use of FLIPR Membrane Potential Dyes for Validation of High-Throughput Screening with the FLIPR and µARCS Technologies: Identification of Ion Channel Modulators Acting on the GABA_A Receptor

University of Applied Sciences Northwestern Switzerland

^* To whom correspondence should be addressed. E-mail: hugo.albrecht{at}fhnw.ch.

	Abstract

Fluorometric imaging plate reader (FLIPR) membrane potential dyes (FMP-Red-Dye and FMP-Blue-Dye) were evaluated for the detection of compounds acting either as positive allosteric modulators or agonists on the GABA_A receptor (GABA_A R). A stable HEK293 cell line with constitutive expression of the rat GABA_A R 1, 2, and 2 genes was used to establish a functional high-throughput screening (HTS) assay based on measurement of the membrane potential change in living cells. The assay was validated with the FLIPR technology for identification of agonists and positive allosteric modulators using GABA and diazepam as model compounds. The FMP-Red-Dye showed better performance than the FMP-Blue-Dye, and the effects induced by GABA and diazepam were comparable to electrophysiology data. Subsequently, the assay was also validated with an ultra-HTS approach known as microarrayed compound screening (µARCS). The LOPAC library was used in a test screen for an initial assessment of the technology. Finally, the FLIPR and µARCS technologies were tested with a larger screening campaign. A focused library of 3520 putative positive modulators was tested with the FLIPR assay, and a diverse subset of 84,480 compounds was selected for screening with the µARCS technology. All hits were subjected to verification using the FLIPR technology, and confirmed hits were subsequently evaluated by EC50 determination. Finally, selected hits were further confirmed with electrophysiology testing. (Journal of Biomolecular ScreeningXXXX:xx-xx)

First published on February 12, 2008, doi:10.1177/1087057108315036

Journal of Biomolecular Screening 2008;13:218.

A more recent version of this article appeared on March 1, 2008


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				D. V. Vasilyev, Q. J. Shan, Y. T. Lee, V. Soloveva, S. P. Nawoschik, E. J. Kaftan, J. Dunlop, S. C. Mayer, and M. R. Bowlby A Novel High-Throughput Screening Assay for HCN Channel Blocker Using Membrane Potential-Sensitive Dye and FLIPR J Biomol Screen, October 1, 2009; 14(9): 1119 - 1128. [Abstract] [PDF]

				E. C. Hollands, T. J. Dale, A. W. Baxter, H. J. Meadows, A. J. Powell, J. J. Clare, and D. J. Trezise Population Patch-Clamp Electrophysiology Analysis of Recombinant GABAA {alpha}1{beta}3{gamma}2 Channels Expressed in HEK-293 Cells J Biomol Screen, August 1, 2009; 14(7): 769 - 780. [Abstract] [PDF]